Exenatide.pdf - ACTIVE LEARNING TEMPLATE Medication Bethany...

This preview shows page 1 out of 1 page.

ACTIVE LEARNING TEMPLATES THERAPEUTIC PROCEDURE A7 Medication STUDENT NAME _____________________________________ MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ CATEGORY CLASS ______________________________________________________________________ ACTIVE LEARNING TEMPLATE: PURPOSE OF MEDICATION Expected Pharmacological Action Complications Contraindications/Precautions Interactions Medication Administration Evaluation of Medication Effectiveness Therapeutic Use Nursing Interventions Client Education Bethany Shelton Exenatide (Byetta) Incretin mimetic Stimulates release of insulin from beta cells of pancreas, mimics enhancement of glucose-dependent insulin secretion, suppresses elevated glucagon secretion, slows gastric emptying (central action Give SubQ; Not recommended in pts with creatinine clearance less than 30 ml/min. May decrease effects of digoxin, lovastatin. May increase bleeding time, risk of bleeding when used with warfarin.

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture